ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

A patient with refractory proliferative lupus nephritis treated with telitacicept: A case report

Chen, Jing-Wen; Zhan, Jing-Yi; Liang, Si-Ping; Wang, Xiao-Dan; Lin, Chang-Song*; Xu, Qiang*广州中医药大学; 广东食品药品职业学院; 1
International Journal of Rheumatic Diseases2023-7DOI: 10.1111/1756-185X.14752
4被引3阅读
引用收藏
分享

摘要

IntroductionSystemic lupus erythematosus (SLE) is a chronic autoimmune disease. Lupus nephritis (LN) is a common type of organ damage which occurs in SLE patients and is characterized by recurrent proteinuria. Activation of B lymphocytes can lead to refractory LN, which is an important pathogenic factor in SLE. B lymphocyte stimulator (BLyS) and A proliferation-inducing ligand (APRIL) are predominantly produced by myeloid cells (monocytes, dendritic cells, neutrophils, etc) to regulate B lymphocyte function. Telitacicept was the first dual-targeting biological drug which targeted both BLyS and APRIL. Telitacicept has passed a phase II clinical trial and has since been approved for the treatment of SLE. Case PresentationWe report a case of SLE confirmed by renal biopsy as proliferative lupus nephritis (PLN) with massive proteinuria, which was treated with telitacicept (European League Against Rheumatism / American College of Rheumatology 2019 standard). During the 19 months of follow-up, the patient's renal function was stable, massive proteinuria was relieved, and creatinine and blood pressure did not increase. ConclusionsDuring the 19 months of telitacicept treatment (160 mg once weekly), PLN reduced blood system damage and proteinuria without increasing the risk of infection.

学科与关键词

关键词
APRILB-cell lymphocyte stimulatorproliferative lupus nephritissystemic lupus erythematosustelitacicept
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
International Journal of Rheumatic Diseases
发表日期
2023-07
卷期
第 26 卷, 第 7 期
页码
1417-1421
DOI
10.1111/1756-185X.14752
语言
ENGLISH
成果收录
SCIE

作者

  • C

    Chen, Jing-Wen (第一作者)

    1 · guangzhou univ chinese med

  • Z

    Zhan, Jing-Yi

    1 · guangzhou univ chinese med

查看全部 6 位作者收起作者
  • L

    Liang, Si-Ping

    1 · guangzhou univ chinese med

  • W

    Wang, Xiao-Dan

    guangdong food & drug vocat coll

  • L

    Lin, Chang-Song (通讯)

    1 · guangzhou univ chinese med

  • X

    Xu, Qiang (通讯)

    1 · guangzhou univ chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417